Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2010-7-14
pubmed:abstractText
Irreversible electroporation (IRE) is a therapeutic technology for the ablation of soft tissues using electrodes to deliver intense but short electric pulses across a cell membrane, creating nanopores that lead to cell death. This phenomenon only affects the cell membrane, leaving the extracellular matrix and sensitive structures intact, making it a promising technique for the treatment many types of tumors. In this paper, we present the first in vivo study to achieve tumor regression using a translatable, clinically relevant single needle electrode for treatment administration. Numerical models of the electric field distribution for the protocol used suggest that a 1000 V/cm field threshold is sufficient to treat a tumor, and that the electric field distribution will slightly decrease if the same protocol were used on a tumor deep seated within a human breast. Tumor regression was observed in 5 out of 7 MDA-MB231 human mammary tumors orthotopically implanted in female Nu/Nu mice, with continued growth in controls.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/20191380-11999950, http://linkedlifedata.com/resource/pubmed/commentcorrection/20191380-15123465, http://linkedlifedata.com/resource/pubmed/commentcorrection/20191380-15758807, http://linkedlifedata.com/resource/pubmed/commentcorrection/20191380-15771276, http://linkedlifedata.com/resource/pubmed/commentcorrection/20191380-16684317, http://linkedlifedata.com/resource/pubmed/commentcorrection/20191380-16830945, http://linkedlifedata.com/resource/pubmed/commentcorrection/20191380-16959028, http://linkedlifedata.com/resource/pubmed/commentcorrection/20191380-17668934, http://linkedlifedata.com/resource/pubmed/commentcorrection/20191380-17668936, http://linkedlifedata.com/resource/pubmed/commentcorrection/20191380-17989772, http://linkedlifedata.com/resource/pubmed/commentcorrection/20191380-18376192, http://linkedlifedata.com/resource/pubmed/commentcorrection/20191380-18412934, http://linkedlifedata.com/resource/pubmed/commentcorrection/20191380-19640131, http://linkedlifedata.com/resource/pubmed/commentcorrection/20191380-19757056, http://linkedlifedata.com/resource/pubmed/commentcorrection/20191380-2834285, http://linkedlifedata.com/resource/pubmed/commentcorrection/20191380-2927449, http://linkedlifedata.com/resource/pubmed/commentcorrection/20191380-8356272
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
1573-7217
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
123
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
295-301
pubmed:dateRevised
2011-7-20
pubmed:meshHeading
pubmed:year
2010
pubmed:articleTitle
Treatment of breast cancer through the application of irreversible electroporation using a novel minimally invasive single needle electrode.
pubmed:affiliation
Bioelectromechanical Systems Lab, Virginia Tech-Wake Forest School of Biomedical Engineering and Sciences, Virginia Tech, 329 ICTAS Building, MC0298, Stranger Street, Blacksburg, VA 24061, USA.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural